EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 182 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2017. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $58,918,000 | +25.3% | 1,737,470 | +7.3% | 0.20% | +18.0% |
| Q1 2017 | $47,003,000 | +14.6% | 1,618,576 | +29.6% | 0.17% | +6.4% |
| Q4 2016 | $41,006,000 | +30.6% | 1,248,668 | +25.4% | 0.16% | +40.2% |
| Q3 2016 | $31,405,000 | +54.0% | 996,034 | +37.4% | 0.11% | +49.3% |
| Q2 2016 | $20,387,000 | +16.3% | 725,018 | +50.3% | 0.08% | +17.2% |
| Q1 2016 | $17,530,000 | +70.1% | 482,252 | +40.7% | 0.06% | +82.9% |
| Q4 2015 | $10,304,000 | +32.1% | 342,726 | +25.2% | 0.04% | +29.6% |
| Q3 2015 | $7,798,000 | -13.0% | 273,700 | +0.7% | 0.03% | +3.8% |
| Q2 2015 | $8,959,000 | +92.5% | 271,900 | +68.0% | 0.03% | +100.0% |
| Q1 2015 | $4,653,000 | +25.7% | 161,800 | +19.1% | 0.01% | +44.4% |
| Q4 2014 | $3,701,000 | +29.3% | 135,900 | +1.2% | 0.01% | +50.0% |
| Q3 2014 | $2,863,000 | +18.9% | 134,300 | +25.3% | 0.01% | +20.0% |
| Q2 2014 | $2,408,000 | – | 107,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |